MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

被引：0
|
作者：
Gonzalez-Astorga, B. [1 ]
Luque, R. [1 ]
Castellon, V. [1 ]
Gonzalez, E. [1 ]
Sanchez, C. [1 ]
Soberino, J. [1 ]
Gonzalez, C. [1 ]
Ruiz, J. [1 ]
Zurita, M. [1 ]
Delgado, J. R. [1 ]
机构：
[1] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3366
引用
收藏
页码：S794 / S794
页数：1
相关论文
共 50 条
  • [21] Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies
    Kurdi, Maher
    Butt, Nadeem Shafique
    Baeesa, Saleh
    Alghamdi, Badrah
    Maghrabi, Yazid
    Bardeesi, Anas
    Saeedi, Rothaina
    Dallol, Ashraf
    Mohamed, Fawaz
    Bari, Mohammed O.
    Samkari, Alaa
    Lary, Ahmed I.
    Alkhayyat, Shadi
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2021, 152 (03) : 541 - 549
  • [22] Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies
    Maher Kurdi
    Nadeem Shafique Butt
    Saleh Baeesa
    Badrah Alghamdi
    Yazid Maghrabi
    Anas Bardeesi
    Rothaina Saeedi
    Ashraf Dallol
    Fawaz Mohamed
    Mohammed O. Bari
    Alaa Samkari
    Ahmed I. Lary
    Shadi Alkhayyat
    [J]. Journal of Neuro-Oncology, 2021, 152 : 541 - 549
  • [23] PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL EXPRESSION OF MGMT IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH TEMAZOLAMIDE
    Balasubramaniam, Anandh
    Santosh, Vani
    Arivazhagan, A.
    Balaram, T.
    Chandramouli, B. A.
    Hegde, A. S.
    Somasundaram, Kumaravel
    Kondaiah, P.
    Rao, M. R. S.
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 646 - 646
  • [24] Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin
    Park, Chul-Kee
    Park, Sung-Hye
    Lee, Se-Hoon
    Kim, Chae-Yong
    Kim, Dong-Wan
    Paek, Sun Ha
    Kim, Dong Gyu
    Heo, Dae Seog
    Kim, Il Han
    Jung, Hee-Won
    [J]. NEUROPATHOLOGY, 2009, 29 (04) : 443 - 449
  • [25] Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide
    Thon, Niklas
    Eigenbrod, Sabina
    Grasbon-Frodl, Eva M.
    Lutz, Juergen
    Kreth, Simone
    Popperl, Gabriele
    Belka, Claus
    Kretzschmar, Hans A.
    Tonn, Joerg-Christian
    Kreth, Friedrich W.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (04): : 441 - 446
  • [26] MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers
    Gutenberg, A.
    Bock, H. C.
    Brueck, W.
    Doerner, L.
    Mehdorn, H. M.
    Roggendorf, W.
    Westphal, M.
    Felsberg, J.
    Reifenberger, G.
    Giese, A.
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 2013, 27 (06) : 772 - 778
  • [27] Prognostic value of MGMT methylation and expression in malignant glioma patients treated with adjuvant temozolomide chemotherapy
    Loeser, S. C.
    Blaschke, B.
    Koehler, S.
    Kreuzmann, A.
    Rapp, M.
    Goeppert, M.
    Reifenberger, G.
    Sabel, M.
    [J]. ACTA NEUROPATHOLOGICA, 2006, 112 (03) : 375 - 375
  • [28] Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
    Larraitz Egaña
    Jaione Auzmendi-Iriarte
    Joaquin Andermatten
    Jorge Villanua
    Irune Ruiz
    Alejandro Elua-Pinin
    Paula Aldaz
    Arrate Querejeta
    Cristina Sarasqueta
    Felix Zubia
    Ander Matheu
    Nicolas Samprón
    [J]. Scientific Reports, 10
  • [29] Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
    Egana, Larraitz
    Auzmendi-Iriarte, Jaione
    Andermatten, Joaquin
    Villanua, Jorge
    Ruiz, Irune
    Elua-Pinin, Alejandro
    Aldaz, Paula
    Querejeta, Arrate
    Sarasqueta, Cristina
    Zubia, Felix
    Matheu, Ander
    Sampron, Nicolas
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
    Gaspar J. Kitange
    Brett L. Carlson
    Ann C. Mladek
    Paul A. Decker
    Mark A. Schroeder
    Wenting Wu
    Patrick T. Grogan
    Caterina Giannini
    Karla V. Ballman
    Jan C. Buckner
    C. David James
    Jann N. Sarkaria
    [J]. Journal of Neuro-Oncology, 2009, 92 : 23 - 31
12345